Orasure Technologies Inc Revenue Growth Rates (OSUR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Orasure Technologies Inc  (NASDAQ: OSUR)
 

OSUR's Revenue Growth by Quarter and Year

Orasure Technologies Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/OSUR/growth
https://api.csimarket.com/api/v1/companies/OSUR/fundamentals
https://api.csimarket.com/api/v1/companies/OSUR/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
OSUR Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 30.91
2nd Quarter June 30.64
1st Quarter March 27.80
FY 89.35

OSURs Annual Revenue
Orasure Technologies Inc's Revenue in the fiscal year 2025 $ 114.20 millions
Orasure Technologies Inc's Revenue in the fiscal year 2024 $ 185.39 millions
Orasure Technologies Inc's Revenue in the fiscal year 2023 $ 404.65 millions
Orasure Technologies Inc's Revenue in the fiscal year 2022 $ 387.48 millions
Orasure Technologies Inc's Revenue in the fiscal year 2021 $ 233.67 millions




OSUR Revenue third quarter 2026 Y/Y Growth Comment
Orasure Technologies Inc achieved in the third quarter 2026, above Company average Revenue increase of 15.45% year on year, to $ 30.91 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 138 other companies have achieved higher Revenue growth. While Orasure Technologies Inc' s Revenue growth of 15.45% ranks overall at the positon no. 3000 in the third quarter 2026.


OSUR Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 15.45 %
2nd Quarter June -1.92 %
1st Quarter March -5.12 %
FY   -

Financial Statements
Orasure Technologies Inc's third quarter 2026 Revenue $ 30.91 millions OSUR's Income Statement
Orasure Technologies Inc's third quarter 2025 Revenue $ 26.77 millions Quarterly OSUR's Income Statement


OSUR Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.87 %
2nd Quarter June 10.22 %
1st Quarter March 3.89 %
FY (Year on Year)   -


Back to OSUR Growth rate Comparisons >> Back to OSUR Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #413
Overall #3000

Revenue Y/Y Growth Statistics
High Average Low
128.87 % 8.6 % -65.11 %
(Mar 31 2023)   (Dec 31 2024)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #413
Overall #3000
Revenue Y/Y Growth Statistics
High Average Low
128.87 % 8.6 % -65.11 %
(Mar 31 2023)   (Dec 31 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Orasure Technologies Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
64.09 % 2.71 % -44.91 %
(Sep 30 2020)  


OSUR's III. Quarter Q/Q Revenue Comment
Orasure Technologies Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.87% quarter on quarter, to $ 30.91 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -14.31% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Orasure Technologies Inc's Revenue growth quarter on quarter, overall rank is 813.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #125
Overall #813
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #125
Overall #813
Revenue Q/Q Growth Statistics
High Average Low
64.09 % 2.71 % -44.91 %
(Sep 30 2020)  


OSUR's III. Quarter Q/Q Revenue Comment
Orasure Technologies Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.87% quarter on quarter, to $ 30.91 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -14.31% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Orasure Technologies Inc's Revenue growth quarter on quarter, overall rank is 813.


Orasure Technologies Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 116.11
Y / Y Revenue Growth (TTM) -7.76 %
Year on Year Revenue Growth Overall Ranking # 3574
Seqeuential Revenue Change (TTM) 3.69 %
Seq. Revenue Growth (TTM) Overall Ranking # 3309


Cumulative Revenue growth Comment
Orasure Technologies Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2026. If the fiscal year would end in Sep 30 2026, Orasure Technologies Inc's annual Revenue improvement would be -7.76% year on year to $116 millions.

In the Healthcare sector 494 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3057 to 3574.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 155
Healthcare Sector # 495
Overall # 3574

Revenue TTM Y/Y Growth Statistics
High Average Low
95.53 %
 7.45 %
-54.19 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 155
Sector # 440
S&P 500 # 3309
Cumulative Revenue growth Comment
Orasure Technologies Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2026. If the fiscal year would end in Sep 30 2026, Orasure Technologies Inc's annual Revenue drop would be -7.76% year on year to $116 millions.

In the Healthcare sector 494 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3057 to 3574.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 155
Healthcare Sector # 495
Overall # 3574

Revenue TTM Y/Y Growth Statistics
High Average Low
95.53 %
7.45 %
-54.19 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 155
Sector # 440
S&P 500 # 3309




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OSUR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Vericel Corporation26.47%$ 26.470 millions
Axogen inc 26.22%$ 26.218 millions
Cardio Diagnostics Holdings Inc 25.74%$ 25.744 millions
Edap Tms Sa25.55%$ 25.549 millions
Lifestance Health Group Inc 25.30%$ 25.303 millions
Rockwell Medical inc 25.21%$ 25.210 millions
Intelligent Bio Solutions Inc 25.19%$ 25.188 millions
The Oncology Institute Inc 24.31%$ 24.313 millions
Vanda Pharmaceuticals Inc 24.10%$ 24.098 millions
Mannkind Corporation24.04%$ 24.035 millions
Castle Biosciences Inc 23.90%$ 23.901 millions
Coherus Oncology inc 23.36%$ 23.360 millions
Prestige Consumer Healthcare Inc 22.93%$ 22.929 millions
Acadia Pharmaceuticals Inc 22.85%$ 22.847 millions
Protalix Biotherapeutics inc 22.82%$ 22.822 millions
Atrium Therapeutics Inc 22.81%$ 22.814 millions
Capsovision Inc 22.44%$ 22.443 millions
Veracyte Inc 22.10%$ 22.105 millions
Radnet Inc 22.07%$ 22.068 millions
Alkermes Plc 21.80%$ 21.804 millions
Alpha Teknova Inc 21.52%$ 21.523 millions
Anteris Technologies Global Corp 20.98%$ 20.979 millions
Trisalus Life Sciences Inc 20.81%$ 20.807 millions
Orthopediatrics Corp20.55%$ 20.551 millions
Alpha Pro Tech Ltd 19.73%$ 19.729 millions
Insulet Corporation19.21%$ 19.213 millions
Abcellera Biologics Inc 18.81%$ 18.805 millions
Schrodinger Inc 18.72%$ 18.715 millions
Procept Biorobotics Corporation18.41%$ 18.414 millions
Supernus Pharmaceuticals inc 18.05%$ 18.047 millions


About Orasure Technologies Inc Revenue Growth Rates (OSUR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Orasure Technologies Inc (CIK 1116463).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001116463-26-000063
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Orasure Technologies Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.